Fluorescent analogues of quinoline reveal amine ligand loss from cis and trans platinum(II) complexes in cancer cells

Journal of Inorganic Biochemistry

Volumn 103, Issue 8, 2009, Pages 1120-1125

  New, Elizabeth J ^a   Roche, Cécile ^a,b   Madawala, Romanthi ^a,b   Zhang, Jenny Z ^a,b   Hambley, Trevor W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ECOLE NORMALE SUPÉRIEURE   (France)

Author keywords

Fluorescence; Ligand displacement; Platinum complexes; Sulfur ligands; Trans activation; Trans effect

Indexed keywords

AMINE; AMMONIA; CISPLATIN; CYSTEINE; GLUTATHIONE; INDOLE DERIVATIVE; LIGAND; METHIONINE; PLATINUM COMPLEX; QUINOLINE DERIVATIVE; TRANSPLATIN;

ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL; CELL LINE; CIS ISOMER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOSOME; FLUORESCENCE; HUMAN; HUMAN CELL; IC 50; ISOMER; LYSOSOME; PHOTON; TRANS ISOMER;

AMINES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; FLUORESCENT DYES; HUMANS; LIGANDS; MOLECULAR STRUCTURE; NEOPLASMS; PLATINUM COMPOUNDS; QUINOLINES; SULFUR;

EID: 67651085563     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2009.05.005     Document Type: Article

References (23)

1. Kelland L.R., Sharp S.Y., O'Neill C.F., Raynaud F.I., Beale P.J., and Judson I.R. J. Inorg. Biochem. 77 (1999) 111-115
2. Cleare M.J., and Hoeschele J.D. Bioinorg. Chem. 2 (1973) 187-210
3. Farrell N., Ha T.T.B., Souchard J.-P., Wimmer F.L., Cros S., and Johnson N.P. J. Med. Chem. 32 (1989) 2240-2241
4. Van Beusichem M., and Farrell N. Inorg. Chem. 31 (1992) 634-639
5. Farrell N. Met. Ions Biol. Syst. 32 (1996) 603-639
6. Skov K.A., Adomat H., Doedee M., and Farrell N. Anti-Cancer Drug Des. 9 (1994) 103-117
7. Farrell N., Kelland L.R., Roberts J.D., and Van Beusichem M. Cancer Res. 52 (1992) 5065-5072
8. Martin R.B. In: Lippert B. (Ed). Chemistry and Biochemistry of a Leading Anticancer Drug (1999), Wiley-VCH, Weinheim
9. Zou Y., Van Houten B., and Farrell N. Biochemistry 32 (1993) 9632-9638
10. Fichtinger-Schepman A.M.J., van der Veer J.L., den Hartog J.H.J., Lohman P.H.M., and Reedijk J. Biochemistry 24 (1985) 707-713
11. Natile G., and Coluccia M. Metal Ions in Biolgical Systems. Metal Complexes in Tumor Diagnosis and as Anticancer Agents vol. 42 (2004), Marcel Dekker, New York pp. 209-250
12. Brabec V. In: Moldave K. (Ed). Prog. Nucleic Acid Res. Mol. Biol. (2002), Academic Press Inc., San Diego, CA 1-68
13. Novakova O., Kasparkova J., Malina J., Natile G., and Brabec V. Nucl. Acids Res. 31 (2003) 6450-6460
14. Reedijk J. Chem. Rev. 99 (1999) 2499-2510
15. Ismail I.M., and Sadler P.J. ACS Symp. Ser. 209 (1983) 171-190
16. Berners-Price S.J., and Kuchel P.W. J. Inorg. Biochem. 38 (1990) 305-326
17. Gibson D., Kasherman Y., Kowarski D., and Freikman I. J. Biol. Inorg. Chem. 11 (2006) 179-188
18. New E.J., Duan R., Zhang J.Z., and Hambley T.W. Dalton Trans. (2009) 3092-3101
19. Kelland L.R., Murrer B.A., Abel G., and Harrap K.R. J. Cell. Pharmacol. 2 (1992) 331-342
20. Chauhan S.S., Liang X.J., Su A.W., Pai-Panandiker A., Shen D.W., Hanover J.A., and Gottesman M.M. Brit. J. Cancer 88 (2003) 1327-1334
21. Safaei R., Larson B.J., Cheng T.C., Gibson M.A., Otani S., Naerdemann W., and Howell S.B. Mol. Cancer Therapeut. 4 (2005) 1595-1604
22. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., and Mitchell J.B. Cancer Res. 47 (1987) 936-942
23. Cai L., Lim K., Ren S., Cadena R.S., and Beck W.T. J. Med. Chem. 44 (2001) 2959-2965